My clinical interests involve the treatment of hematologic malignancies, including acute and chronic leukemias, lymphomas and myeloma. Treatment approaches include both standard-dose chemotherapy and immunotherapy as well as high-dose therapy combined with autologous or allogeneic (donor) stem transplantation.
My clinical research interests concern the development of novel strategies for re-building immune system function after autologous stem cell transplantation for myeloma and leukemia and specifically involve the use of post-transplant cellular and vaccine-based immunotherapy. The goal of this work is to improve upon post-transplant outcomes including the duration of disease responses and the prevention of infections.
In 2006, I was chosen by the Leukemia & Lymphoma Society to receive their prestigious Stohlman Scholar Award for outstanding contributions to the advancement of blood cancer research. The Stohlman award is given to Society Scholars who are in the fifth year of their research. Society Scholars are highly qualified investigators who have demonstrated their ability to conduct original research bearing on leukemia, lymphoma or myeloma.